Show simple item record

dc.contributor.authorAbel, Garyen
dc.contributor.authorSaunders, Catherineen
dc.contributor.authorLyratzopoulos, Georgiosen
dc.date.accessioned2015-12-21T13:17:48Z
dc.date.available2015-12-21T13:17:48Z
dc.date.issued2016-01-18en
dc.identifier.citationAbel et al. Cancer Epidemiology (2016) Vol. 41, pp. 34-41. doi: 10.1016/j.canep.2015.12.010en
dc.identifier.issn1877-7821
dc.identifier.urihttps://www.repository.cam.ac.uk/handle/1810/253069
dc.description.abstractBACKGROUND: Surveys of the experience of cancer patients are increasingly being introduced in different countries and used in cancer epidemiology research. We examine how sampling processes, post-sampling mortality and survey non-response influence the representativeness of cancer patient surveys. METHODS: We examined predictors of post-sampling mortality and non-response among patients initially included in the sampling frame of the English Cancer Patient Experience Survey. We also compared the respondents’ diagnostic case-mix to other relevant populations of cancer patients, including incident and prevalent cases. RESULTS: Of 109,477 initially sampled cancer patients, 6,273 (5.7%) died between sampling and survey mail-out. Older age and diagnosis of brain, lung and pancreatic cancer were associated with higher risk of post-sampling mortality. The overall response rate was 67% (67,713 respondents), being >70% for the most affluent patients and those diagnosed with colon or breast cancer and <50% for Asian or Black patients, those under 35 and those diagnosed with brain cancer. The diagnostic case-mix of respondents varied substantially from incident or prevalent cancer cases. CONCLUSIONS: Respondents to the English Cancer Patient Experience Survey represent a population of recently treated cancer survivors. Although patient survey data can provide unique insights for improving cancer care quality, features of survey populations need to be acknowledged when analysing and interpreting findings from studies using such data.
dc.description.sponsorshipThe authors wish to thank the Department of Health as the principal investigator of the 2010 Cancer Patient Experience Survey, Quality Health as the data collector and for making available the anonymous sampling frame, and all the National Health Service Acute Trusts in England who supported the survey. GL is supported by a Cancer Research UK Clinician Scientist Fellowship (A18180). The views expressed in this publication are those of the authors and not necessarily those of any funder or any other organisation or institution.
dc.languageEnglishen
dc.language.isoenen
dc.publisherElsevier
dc.rightsAttribution 2.0 UK: England & Wales
dc.rights.urihttp://creativecommons.org/licenses/by/2.0/uk/
dc.subjectpatienten
dc.subjectsurveyen
dc.subjectnon-responseen
dc.subjectmortalityen
dc.subjectcanceren
dc.subjectdisparitiesen
dc.titlePost-sampling mortality and non-response patterns in the English Cancer Patient Experience Survey: Implications for epidemiological studies based on surveys of cancer patientsen
dc.typeArticle
dc.description.versionThis is the final version of the article. It first appeared from Elsevier via http://dx.doi.org/10.1016/j.canep.2015.12.010en
prism.endingPage41
prism.publicationDate2016en
prism.publicationNameCancer Epidemiologyen
prism.startingPage34
prism.volume41en
dc.rioxxterms.funderCRUK
dc.rioxxterms.projectidA18180
dcterms.dateAccepted2015-12-18en
rioxxterms.versionofrecord10.1016/j.canep.2015.12.010en
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/all-rights-reserveden
rioxxterms.licenseref.startdate2016-01-18en
dc.contributor.orcidSaunders, Catherine [0000-0002-3127-3218]
dc.contributor.orcidLyratzopoulos, Georgios [0000-0002-2873-7421]
dc.identifier.eissn1877-783X
rioxxterms.typeJournal Article/Reviewen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution 2.0 UK: England & Wales
Except where otherwise noted, this item's licence is described as Attribution 2.0 UK: England & Wales